Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Vital Therapies, Inc. (NASDAQ: VTL).

Full DD Report for VTL

You must become a subscriber to view this report.


Recent News from (NASDAQ: VTL)

Today's Research Reports on Stocks to Watch: Bausch Health Companies and Vital Therapies
NEW YORK, NY / ACCESSWIRE / September 13, 2018 / Bausch Health Companies together with Salix's licensors Cedars-Sinai Medical Center and Alfasigma SpA resolve the outstanding intellectual property litigation with Actavis Laboratories. Vital Therapies’ shares dived deep in red followin...
Source: ACCESSWIRE IA
Date: September, 13 2018 08:00
Midday Gainers / Losers (09/12/2018)
Gainers:  NMRD +47% . XBIT +27% . CIFS +23% . ARCI +18% . GLPG +17% . SLDB +17% . VVUS +15% . MHLD +15% . CDXC +14% . BHC +13% . More news on: Nemaura Medical, Inc., Xbiotech, China Internet Nationwide Financial Services Inc., Stocks on the move, , ...
Source: SeekingAlpha
Date: September, 12 2018 12:43
Premarket Losers as of 9:05 am (9/12/2018)
VTL   -89%  as VTL-308 fails to achieve primary and secondary endpoints of improvement in survival. More news on: Vital Therapies, Inc., PolarityTE, Inc., Renren Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 12 2018 09:09
Premarket analyst action - healthcare
Zealand Pharma A/S (NASDAQ: ZEAL ) resumed with Overweight rating at Morgan Stanley following its $205M deal with Royalty Pharma. More news on: Zealand Pharma, Intercept Pharmaceuticals, Vital Therapies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 12 2018 08:34
Vital Therapies down 82% as VTL-308 fails to achieve primary and secondary endpoints of improvement in survival
Vital Therapies (NASDAQ: VTL ) announces that, while there was a numerical improvement in survival in the ELAD-treated group between three months and one year following randomization, the VTL-308 study failed to meet the primary endpoint of a significant improvement in overall surviva...
Source: SeekingAlpha
Date: September, 12 2018 06:07

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-140.470.49820.600.40723,204,499
2017-03-104.354.454.454.151,587
2017-03-094.254.304.354.1032,158
2017-03-084.354.254.354.2541,415
2017-03-074.304.354.454.3037,388

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1395,855329,12629.1241Cover
2018-12-1245,715710,4826.4344Cover
2018-12-1193,414447,83520.8590Cover
2018-12-10179,988319,74856.2906Short
2018-12-07234,485372,00863.0322Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VTL.


About Vital Therapies, Inc. (NASDAQ: VTL)

Logo for Vital Therapies, Inc. (NASDAQ: VTL)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $271,160,730 - 05/18/2018
  • Issue and Outstanding: 42,368,864 - 02/28/2018

 


Recent Filings from (NASDAQ: VTL)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 07 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: June, 13 2018
Correspondence from the Filer to the SEC
Filing Type: CORRESPFiling Source: edgar
Filing Date: June, 11 2018
Pre-effective amendment to an S-3 filing
Filing Type: S-3/AFiling Source: edgar
Filing Date: June, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 08 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: June, 08 2018
Correspondence from the Filer to the SEC
Filing Type: CORRESPFiling Source: edgar
Filing Date: June, 08 2018
Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: June, 08 2018

 

 


Daily Technical Chart for (NASDAQ: VTL)

Daily Technical Chart for (NASDAQ: VTL)


Stay tuned for daily updates and more on (NASDAQ: VTL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: VTL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VTL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VTL and does not buy, sell, or trade any shares of VTL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/